drugset / Trial / NCT01228838

Study of NGX-1998 for the Treatment of Postherpetic Neuralgia

NCT01228838

Phase 2 Completed 183 enrolled NeurogesX
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to assess the efficacy, safety and tolerability of NGX-1998 applied for 5 minutes for the treatment of postherpetic neuralgia (PHN).

Timeline

Start
2010-10
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 10 % Topical
Subject Capsaicin Small molecule 20 % Topical